1.14 USD
▼-0.13-10.24%
盘后 1.17 +2.63%
2026-11-20
市值
$922.92K
市盈率
—
EPS
-39.60
股息率
—
52 周区间
1.14 – 1,344.00
成交量
68.49K
Beta
-0.27
目标价
—
52W 低 1.1452W 高 1,344.00
价格走势
公司简介
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also ...